{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:50:56Z","timestamp":1776408656809,"version":"3.51.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82260046"],"award-info":[{"award-number":["82260046"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Translational Research Grant of National Clinical Research Center for Hematologic Diseases","award":["2021WWC03"],"award-info":[{"award-number":["2021WWC03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06963-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:28:32Z","timestamp":1774963712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nomogram based on serum interleukin-33 levels and clinical characteristics for predicting overall survival in hematologic malignancy patients receiving haplo-HDPSCT"],"prefix":"10.1007","volume":"105","author":[{"given":"Gulisitan","family":"Aisikaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaile","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"6963_CR1","first-page":"151","volume":"16","author":"W Owattanapanich","year":"2025","unstructured":"Owattanapanich W, Karoopongse E, Kittivorapart J et al (2025) Optimizing Haploidentical Hematopoietic Stem Cell Transplantation: Enhancing Outcomes in Hematologic Malignancies in Resource-Limited Settings. J Blood Med 16:151\u2013161 Published 2025 Mar 30","journal-title":"J Blood Med"},{"key":"6963_CR2","first-page":"20","volume":"2","author":"L Gao","year":"2015","unstructured":"Gao L, Zhang X (2015) Haploidentical hematopoietic transplantation without T-cell depletion: current status and future perspectives. Stem Cell Investig 2:20","journal-title":"Stem Cell Investig"},{"key":"6963_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtos.2023.09.006","volume":"30","author":"P Steven","year":"2023","unstructured":"Steven P, Perez VL, Sharma A (2023) Murine models of graft versus host disease (GVHD): focus on ocular GVHD. Ocul Surf 30:179\u2013186","journal-title":"Ocul Surf"},{"issue":"10","key":"6963_CR4","first-page":"1015e1","volume":"30","author":"L Sisinni","year":"2024","unstructured":"Sisinni L et al (2024) Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH. Transpl Cell Ther 30(10):1015e1\u20131015e13Grupo Espa\u00f1ol de Trasplante Hematopoy\u00e9tico","journal-title":"Transpl Cell Ther"},{"issue":"1","key":"6963_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s13287-022-03170-x","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y et al (2022) Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation. Stem Cell Res Ther 13(1):485","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"6963_CR6","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.bbmt.2014.08.001","volume":"20","author":"L Gao","year":"2014","unstructured":"Gao L et al (2014) Effects of priming with recombinant human granulocyte colony-stimulating factor on conditioning regimen for high-risk acute myeloid leukemia patients undergoing human leukocyte antigen-haploidentical hematopoietic stem cell transplantation: a multicenter randomized controlled study in southwest China. Biol Blood Marrow Transpl 20(12):1932\u20131939","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"6963_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.exphem.2016.04.005","volume":"44","author":"M Byrne","year":"2016","unstructured":"Byrne M et al (2016) Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Exp Hematol 44(7):567\u2013573","journal-title":"Exp Hematol"},{"issue":"4","key":"6963_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/eji.201747177","volume":"48","author":"Y Song","year":"2018","unstructured":"Song Y et al (2018) IL-12\/IL-18-preactivated donor NK cells enhance GVL effects and mitigate GvHD after allogeneic hematopoietic stem cell transplantation. Eur J Immunol 48(4):670\u2013682","journal-title":"Eur J Immunol"},{"issue":"4","key":"6963_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/14653240802129885","volume":"10","author":"SJ Lin","year":"2008","unstructured":"Lin SJ, Kuo ML (2008) Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function. Cytotherapy 10(4):397\u2013405","journal-title":"Cytotherapy"},{"key":"6963_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.806529","volume":"12","author":"J Campe","year":"2021","unstructured":"Campe J, Ullrich E (2021) T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy? Front Immunol 12:806529","journal-title":"Front Immunol"},{"key":"6963_CR11","doi-asserted-by":"publisher","first-page":"1478565","DOI":"10.3389\/fpsyt.2024.1478565","volume":"15","author":"L Huo","year":"2024","unstructured":"Huo L et al (2024) The construction and validation of the novel nomograms for the risk prediction of prenatal depression: a cross-sectional study. Front Psychiatry 15:1478565","journal-title":"Front Psychiatry"},{"issue":"12","key":"6963_CR12","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.1002\/cam4.2452","volume":"8","author":"L Chen","year":"2019","unstructured":"Chen L et al (2019) Prognostic nomograms to predict overall survival and cancer-specific survival in patients with pelvic chondrosarcoma. Cancer Med 8(12):5438\u20135449","journal-title":"Cancer Med"},{"issue":"5","key":"6963_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/cam4.1021","volume":"6","author":"Y Li","year":"2017","unstructured":"Li Y et al (2017) Nomograms to estimate long-term overall survival and tongue cancer-specific survival of patients with tongue squamous cell carcinoma. Cancer Med 6(5):1002\u20131013","journal-title":"Cancer Med"},{"issue":"3","key":"6963_CR14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/MPA.0000000000001779","volume":"50","author":"Z Song","year":"2021","unstructured":"Song Z et al (2021) Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival of Patients With Pancreatic Neuroendocrine Tumors: A Population-Based Study. Pancreas 50(3):414\u2013422","journal-title":"Pancreas"},{"issue":"26","key":"6963_CR15","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","volume":"138","author":"M Heuser","year":"2021","unstructured":"Heuser M et al (2021) 2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party. Blood 138(26):2753\u20132767","journal-title":"Blood"},{"issue":"8","key":"6963_CR16","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML et al (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106(8):2912\u20132919","journal-title":"Blood"},{"key":"6963_CR17","unstructured":"Przepiorka D et al (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant, 15(6): pp. 825-8"},{"issue":"1","key":"6963_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.blre.2005.01.007","volume":"20","author":"ME Horwitz","year":"2006","unstructured":"Horwitz ME, Sullivan KM (2006) Chronic graft-versus-host disease. Blood Rev 20(1):15\u201327","journal-title":"Blood Rev"},{"key":"6963_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-015-0182-9","volume":"8","author":"YJ Chang","year":"2015","unstructured":"Chang YJ et al (2015) Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 8:84","journal-title":"J Hematol Oncol"},{"issue":"8","key":"6963_CR20","first-page":"667","volume":"40","author":"L Ying","year":"2019","unstructured":"Ying L (2019) Clinical study on the treatment of patients with malignant hematopoietic stem cell transplantation with reduced dose pretreatment of haplotype peripheral blood hematopoietic stem cell transplantation for patients with malignant hematologic tumors over 50 years old. Chin J Hematol 40(8):667\u2013672","journal-title":"Chin J Hematol"},{"issue":"12","key":"6963_CR21","first-page":"1564","volume":"40","author":"PN Nan","year":"2017","unstructured":"Nan PN (2017) Research on the characteristics of Th9 cell reconstruction after allogeneic hematopoietic stem cell transplantation. J Xinjiang Med Univ 40(12):1564\u20131568","journal-title":"J Xinjiang Med Univ"},{"issue":"8","key":"6963_CR22","first-page":"3623","volume":"9","author":"N Pang","year":"2017","unstructured":"Pang N et al (2017) Peripheral blood Th9 cells reconstitution and its relationship with acute graft-versus-host disease after matched-sibling peripheral blood hematopoietic stem cell transplantation. Am J Transl Res 9(8):3623\u20133632","journal-title":"Am J Transl Res"},{"issue":"7","key":"6963_CR23","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1172\/JCI85796","volume":"126","author":"A Saha","year":"2016","unstructured":"Saha A et al (2016) Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest 126(7):2642\u20132660","journal-title":"J Clin Invest"},{"issue":"1","key":"6963_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbmt.2018.08.028","volume":"25","author":"A Ijaz","year":"2019","unstructured":"Ijaz A et al (2019) Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic Transplantation. Biol Blood Marrow Transpl 25(1):94\u201399","journal-title":"Biol Blood Marrow Transpl"},{"issue":"24","key":"6963_CR25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.scib.2021.06.002","volume":"66","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu QF, Lin R et al Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial. Sci Bull (Beijing). (2021) ;66(24):2498\u20132505. https:\/\/doi.org\/10.1016\/j.scib.2021.06.002","journal-title":"Sci Bull (Beijing)"},{"key":"6963_CR26","doi-asserted-by":"publisher","unstructured":"Nagler A, Labopin M, Houhou M et al (2021) Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. J Hematol Oncol 14.\u00a0https:\/\/doi.org\/10.1186\/s13045-021-01065-7","DOI":"10.1186\/s13045-021-01065-7"},{"key":"6963_CR27","doi-asserted-by":"publisher","unstructured":"Levine JE, Braun TM, Harris AC et al (2015) A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study. Lancet Haematol 2. https:\/\/doi.org\/10.1016\/S2352-3026(14)00035-0","DOI":"10.1016\/S2352-3026(14)00035-0"},{"issue":"6","key":"6963_CR28","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S et al (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117(6):1538\u20131549","journal-title":"J Clin Invest"},{"issue":"1","key":"6963_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.0606854104","volume":"104","author":"V Carriere","year":"2007","unstructured":"Carriere V et al (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104(1):282\u2013287","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6963_CR30","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","volume":"3","author":"C Moussion","year":"2008","unstructured":"Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019? PLoS One 3(10):e3331","journal-title":"PLoS One"},{"issue":"1","key":"6963_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-5793(93)81333-U","volume":"318","author":"K Yanagisawa","year":"1993","unstructured":"Yanagisawa K et al (1993) Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 318(1):83\u201387","journal-title":"FEBS Lett"},{"issue":"1","key":"6963_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1006\/bbrc.1999.1469","volume":"264","author":"S Tominaga","year":"1999","unstructured":"Tominaga S et al (1999) Presence and expression of a novel variant form of ST2 gene product in human leukemic cell line UT-7\/GM. Biochem Biophys Res Commun 264(1):14\u201318","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"6963_CR33","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.4049\/jimmunol.1003487","volume":"186","author":"MM Zaiss","year":"2011","unstructured":"Zaiss MM et al (2011) IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J Immunol 186(11):6097\u20136105","journal-title":"J Immunol"},{"key":"6963_CR34","doi-asserted-by":"publisher","unstructured":"Matta BM, Lott JM, Mathews LR et al (2014) IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R\/ST2\u2009+\u2009regulatory T cells. J Immunol 193(8):4010\u20134020. https:\/\/doi.org\/10.4049\/jimmunol.1400481","DOI":"10.4049\/jimmunol.1400481"},{"key":"6963_CR35","doi-asserted-by":"publisher","unstructured":"Schiering C, Krausgruber T, Chomka A\u00a0et al (2014) The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513. https:\/\/doi.org\/10.1038\/nature13577","DOI":"10.1038\/nature13577"},{"issue":"4","key":"6963_CR36","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00277-024-05639-6","volume":"103","author":"J Lucero","year":"2024","unstructured":"Lucero J et al (2024) Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Ann Hematol 103(4):1187\u20131196","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06963-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06963-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:58:34Z","timestamp":1776405514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06963-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6963"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06963-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present work gained approval from the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Ethics Approval No. S240104-11). All subjects provided informed consents. The present work was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments, or with comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}